Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Immunic Inc
10VACurrent price
1.07 EUR
0 EUR (0.00%)
Last closed
1.15 USD
Company
www.immunic-therapeutics.com
ISIN
US4525EP1011
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
106 293 216 USD
Yield for 12 month
+9.00 %
1Y
3Y
5Y
10Y
15Y
10VA
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York. Address: 1200 Avenue of the Americas, New York, NY, United States, 10036
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13.25 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-111 000 USD
Last Year
-77 000 USD
Current Quarter
–
Last Quarter
-31 000 USD
Key Figures 10VA
1 year
3 years
5 years
10 years
EBITDA
-93 532 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-66.8 %
PEG Ratio
–
Return On Equity TTM
-143.47 %
Wall Street Target Price
13.25 USD
Revenue TTM
–
Book Value
0.64 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.5 USD
Diluted Eps TTM
-1.5 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 10VA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 10VA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:40
Payout Ratio
–
Last Split Date
15.04.2019
Dividend Date
15.04.2019
Stock Valuation 10VA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.2135
Price Book MRQ
1.6862
Financials 10VA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 10VA
For 52 weeks
0.97 USD
2.11 USD
50 Day MA
1.47 USD
Shares Short Prior Month
2 681 886
200 Day MA
1.34 USD
Short Ratio
5.76
Shares Short
3 466 235
Short Percent
3.88 %
BeatStart